1. Каталог >
  2. Клеточные линии, штаммы, среды >
  3. Культуральные среды >
  4. Культуральные среды по тканям >
  5. Скелетная мускулатура/кости/суставы: среды >

Культуральная среда для синовиоцитов человека

Human Synoviocyte Media

Специализированная среда с ингридиентами и добавками, оптимизированными для уникальных требований синовиальных клеток, обеспечивающая оптимальные условия культивирования, здоровье клеток,  целостность и воспроизводимость данных.

Использовать для:

Документы



Публикации

2015

Auer, J. M. Bader, J. Fischer, H. Kettenberger, M. Hilger, S. Lorenz, and J. Moelleken. 2015. BISPECIFIC ANTIBODIES AGAINST HUMAN TWEAK AND HUMAN 1L17 AND USES THEREOF. Patent Application 20150132307 A1.
Yoshioka, R.0, Y. Kita, A. Nagahira, A. Manno, N. Makita, U. Tomita, and M. Murakawa. 2015. Quantitative analysis of cadherin-11 and β-catenin signalling during proliferation of rheumatoid arthritis-derived synovial fibroblast cells. Journal of Pharmacy and Pharmacology.
2012
Brys, R., N. Vangeghinste, P. Tomme, H. Johanus, and M. Klaassen. 2012. Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases. Patent US 8097408 B2.
Evanko, S.P., S. Potter-Perigo, P.L. Bollyky, G.T. Nepom, and T.N. Wight. 2012. Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration. Matrix Biology. 31:90-100.
Hsu, J., Y. Gu, S.-L. Tan, S. Narula, J.A. DeMartino, and C. Liao. 2012. Bruton's Tyrosine Kinase mediates platelet receptor-induced generation of microparticles: A potential mechanism for amplification of inflammatory responses in rheumatoid arthritis synovial joints. Immunology letters, 150:97-104.
Yamaguchi, A., K. Nozawa, M. Fujishiro, M. Kawasaki, K. Takamori, H. Ogawa, I. Sekigawa, and Y. Takasaki. 2012b. Estrogen inhibits apoptosis and promotes CC motif chemokine ligand 13 expression on synovial fibroblasts in rheumatoid arthritis. Immunopharmacology and Immunotoxicology. 34:852-857.
2011
Brys, R., N. Vandeghinste, and P. Tomme. 2011. Methods for identification, and compounds useful for the treatment of degenerative and inflammatory diseases. Patent US 7919259 B2.
Chen, D.P., C.K. Wong, L.S. Tam, E.K. Li, and C.W. Lam. 2011. Activation of human fibroblast-like synoviocytes by uric acid crystals in rheumatoid arthritis. Cellular & molecular immunology. 8:469-478.
Chen, D.-P., C.-K. Wong, P.-C. Leung, K.-P. Fung, C.B.-S. Lau, C.-P. Lau, E.K.-M. Li, L.-S. Tam, and C.W.-K. Lam. 2011b. Anti-inflammatory activities of Chinese herbal medicine sinomenine and Liang Miao San on tumor necrosis factor-α-activated human fibroblast-like synoviocytes in rheumatoid arthritis. Journal of ethnopharmacology. 137:457-468.
2010
Brys, R., N. Vandeghinste, and P. Tomme. 2010. Methods for identification, and compounds useful for the treatment of degenerative and inflammatory diseases. Patent Application EP 2 256 197 A1.
El-Beialy, W., N. Galal, Y. Deyama, Y. Yoshimura, K. Suzuki, K. Tei, and Y. Totsuka. 2010. Effects of Estrogen on PMCA 2 and 4 in Human Fibroblast-like Synovial Cells and Mouse Macrophage-like Cells. Endocrine J, 57:93-97.
Freimanis, G., P. Hooley, H.D. Ejtehadi, H. Ali, A. Veitch, P. Rylance, A. Alawi, J. Axford, A. Nevill, and P.G. Murray. 2010. A role for human endogenous retrovirusK (HML2) in rheumatoid arthritis: investigating mechanisms of pathogenesis. Clinical & Experimental Immunology. 160:340-347.
Suzuki, M., M. Hashizume, H. Yoshida, and M. Mihara. 2010. Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule. Rheumatol Int. 30:309-315.
2009
Nakamachi, Y., S. Kawano, M. Takenokuchi, K. Nishimura, Y. Sakai, T. Chin, R. Saura, M. Kurosaka, and S. Kumagai. 2009. MicroRNA124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblastlike synoviocytes from patients with rheumatoid arthritis. Arthritis & Rheumatism. 60:1294-1304.
Brys, R,. N. Vandeghinste, P. Tomme, and H. Klaassen. 2009. Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases. Patent US 7485468 B2.
Laurent, A., M. Proulx, and J. Jaquith. 2009. Functionalized pyrrolidines and use thereof as iap inhibitors. Patent Application US 20110117081 A1.


НазваниеКодЦена
For general cryopreservation of most primary cells. Contains FBS & DMSO. 040-50 по запросу



НазваниеКодЦена
100 ml each of HBSS, Trypsin/EDTA & Trypsin Neutralizing Solution 090K по запросу



НазваниеКодЦена
Basal medium (contains no growth supplement).В  Add GS before use. 414-500 по запросу



НазваниеКодЦена
All-in-one ready-to-use 415-500 по запросу
Growth medium without antibiotics 415A-500 по запросу
Growth medium without FBS 415F-500 по запросу



НазваниеКодЦена
Basal medium & growth supplement sold together packaged separately 415K-500 по запросу



НазваниеКодЦена
Added to Basal Medium to create Growth Medium 415-GS по запросу




Информация представлена исключительно в ознакомительных целях и ни при каких условиях не является публичной офертой